-logo-1200x675.png){kind=logo}
CellaVision AB (publ) (OTCMKTS:CLVSF – Get Free Report)’s share price was down 25.6% on Thursday . The stock traded as low as $19.28 and last traded at $19.28. Approximately 157 shares traded hands during trading, a decline of 59% from the average daily volume of 383 shares. The stock had previously closed at $25.91.
CellaVision AB (publ) Price Performance
The stock’s 50 day moving average is $21.56 and its two-hundred day moving average is $23.60.
About CellaVision AB (publ)
CellaVision AB (publ) develops and sells instruments, software, and reagents for blood and body fluids analysis in Sweden and internationally. The company provides CellaVision DM1200 and CellaVision DM9600, designs to automate and simplify the process of performing blood and body fluid differentials; CellaVision DC-1, an analyzer to enable low-volume hematology labs to implement CellaVisions digital methodology for performing blood cell; and DIFF-Line that automates and digitizes the process of analyzing peripheral blood smears.
See Also
- Five stocks we like better than CellaVision AB (publ)
- Most Volatile Stocks, What Investors Need to Know
- Bloom Energy: Powering the Future With Decentralized Energy
- Expert Stock Trading Psychology Tips
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Receive News & Ratings for CellaVision AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CellaVision AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.
